ABCC2 and metabolic dysfunction-associated steatohepatitis: Oatp1a1 protein expression decreased to 57% of control in the WT-NASH group, to 11% of control in the Mrp2–/–-NASH group, and was not detected in the Slco1a/1b cluster knockout animals (Fig. 5A and B, upper left panels).